Digital Health · Market statistics

Artificial Intelligence (AI) in Pharma market statistics

Size and growth in 33 countries and regions, with clinical trials and research from public sources.

Most clinical trials

Active trials by country (ClinicalTrials.gov)

  1. 1 China 142
  2. 2 US 114
  3. 3 Italy 41
  4. 4 France 38
  5. 5 Spain 29
  6. 6 Germany 23
  7. 7 Canada 19
  8. 8 UK 18
See every trial on ClinicalTrials.gov (opens in a new tab)

Artificial Intelligence (AI) in Pharma by country and region

Artificial Intelligence (AI) in Pharma market size, growth and active trials in every geography we cover
Place20232033 (projected)CAGR Active trialsReport
World – – – 658 Report on Artificial Intelligence (AI) in Pharma in Global
APAC – – – 163 Report on Artificial Intelligence (AI) in Pharma in APAC
Africa – – – 14 Report on Artificial Intelligence (AI) in Pharma in Africa
Europe – – – 130 Report on Artificial Intelligence (AI) in Pharma in Europe
Latin America – – – 12 Report on Artificial Intelligence (AI) in Pharma in Latin America
Middle East – – – 2 Report on Artificial Intelligence (AI) in Pharma in Middle East
North America – – – 127 Report on Artificial Intelligence (AI) in Pharma in North America
Australia – – – 3 Report on Artificial Intelligence (AI) in Pharma in Australia
Brazil – – – 8 Report on Artificial Intelligence (AI) in Pharma in Brazil
Canada – – – 19 Report on Artificial Intelligence (AI) in Pharma in Canada
China – – – 142 Report on Artificial Intelligence (AI) in Pharma in China
Ecuador – – – 0 Report on Artificial Intelligence (AI) in Pharma in Ecuador
Egypt – – – 9 Report on Artificial Intelligence (AI) in Pharma in Egypt
France – – – 38 Report on Artificial Intelligence (AI) in Pharma in France
Germany – – – 23 Report on Artificial Intelligence (AI) in Pharma in Germany
Hong Kong – – – 8 Report on Artificial Intelligence (AI) in Pharma in Hong Kong
India – – – 3 Report on Artificial Intelligence (AI) in Pharma in India
Italy – – – 41 Report on Artificial Intelligence (AI) in Pharma in Italy
Japan – – – 3 Report on Artificial Intelligence (AI) in Pharma in Japan
Kenya – – – 1 Report on Artificial Intelligence (AI) in Pharma in Kenya
Malaysia – – – 1 Report on Artificial Intelligence (AI) in Pharma in Malaysia
Mexico – – – 5 Report on Artificial Intelligence (AI) in Pharma in Mexico
New Zealand – – – 0 Report on Artificial Intelligence (AI) in Pharma in New Zealand
Philippines – – – 1 Report on Artificial Intelligence (AI) in Pharma in Philippines
Russia – – – 1 Report on Artificial Intelligence (AI) in Pharma in Russia
Saudi Arabia – – – 1 Report on Artificial Intelligence (AI) in Pharma in Saudi Arabia
Singapore – – – 8 Report on Artificial Intelligence (AI) in Pharma in Singapore
South Africa – – – 4 Report on Artificial Intelligence (AI) in Pharma in South Africa
Spain – – – 29 Report on Artificial Intelligence (AI) in Pharma in Spain
Thailand – – – 1 Report on Artificial Intelligence (AI) in Pharma in Thailand
UAE – – – 1 Report on Artificial Intelligence (AI) in Pharma in UAE
UK – – – 18 Report on Artificial Intelligence (AI) in Pharma in UK
US – – – 114 Report on Artificial Intelligence (AI) in Pharma in US

"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.

Latest research 4,733 papers since 2021

  1. Multi-criteria drug ranking for prostate cancer using graph-theoretic descriptors and fuzzy machine learning with MARCOS decision analysis. Computational biology and chemistry, 2026
  2. Graphics processing unit-accelerated quantum simulation for molecular biology and drug discovery: algorithms, platforms, and emerging applications. Briefings in bioinformatics, 2026
  3. QRxVision: Multimodal QR Encoding and Computer Vision for Domain-Specific Drug Discovery. Journal of chemical information and modeling, 2026
  4. The Transformation of Oncology Drug Development in China: Toward a New Phase of Innovation. Cancer discovery, 2026
  5. Structural dependence of pharmaceutical transformation and toxicity evolution during water oxidation and disinfection. Journal of hazardous materials, 2026
Search all of them on PubMed (opens in a new tab)

Key companies in Artificial Intelligence (AI) in Pharma

IBM Watson Health Google DeepMind Microsoft NVIDIA Corporation Atomwise, Inc. BenevolentAI BioXcel Therapeutics, Inc. Insilico Medicine Exscientia PathAI

Quick answers

How many clinical trials are running in Artificial Intelligence (AI) in Pharma?

ClinicalTrials.gov lists 658 active trials worldwide (recruiting, about to start or running), most of them in China, as of 10 Nov 2026.

How much research is published on Artificial Intelligence (AI) in Pharma?

PubMed lists about 4,733 papers on the topic since 2021.

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.

Get a free sample The global Artificial Intelligence (AI) in Pharma report: contents and sample pages, free. Request sample Consult us Need Artificial Intelligence (AI) in Pharma numbers for your plan? Our analysts can help. Talk to us Buy the report The full global report, $4,000. Every country report is in the table above. Buy now

All market statistics